Minneapolis, Minnesota 55402
T: +1 612 766 8766C: +1 651 261 3467F: +1 612 766 1600
Ralph Hall has extensive experience in the areas of FDA, health care law and corporate compliance, including the application of those regulatory systems to the medical device industry. He has expertise in the design and implementation of regulatory compliance programs and with FDA enforcement actions. Ralph also has experience in developing and implementing cross disciplinary corporate legal strategies, corporate law department organization and management, and general corporate counseling.
Prior to rejoining Faegre Baker Daniels, Ralph was with Guidant Corporation where he served as Senior Vice President and Deputy General Counsel – Litigation and Compliance. Also at Guidant, he was Special Counsel to the Board of Director's Compliance Committee and the corporation's Compliance Office. Earlier, Ralph was General Counsel of Guidant's Cardiac Rhythm Management Group — a billion dollar plus business. Before joining Guidant, Ralph was with Eli Lilly and Company where he served in a number of legal roles, including chief environmental counsel.
Ralph also serves as a Professor of Practice at the University of Minnesota Law School where he teaches courses in FDA law, corporate compliance and negotiation. Ralph has written extensively on FDA and compliance matters, as well as spoken frequently at legal seminars on a variety of subjects.
*Your message has been successfully sent.
In considering prior results, please be aware that: (i) each legal matter is
unique; (ii) prior results are not necessarily representative of all our
matters; and (iii) you should not rely on prior results to predict future
success in similar matters.
Copyright © 2000-2015 Faegre Baker Daniels LLP.
All Rights Reserved. | Disclaimer
Notes: Please do not send confidential information or
sensitive materials through this form.
Transmission of information to us via this feature does not establish an attorney-client relationship. Do not send any information that you would have treated confidentially.